Logo image of AQNB

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:AQNB - US0158578080

25.73 USD
-0.01 (-0.04%)
Last: 12/2/2025, 8:27:07 PM
25.7 USD
-0.03 (-0.12%)
After Hours: 12/2/2025, 8:27:07 PM
Fundamental Rating

3

AQNB gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 26 industry peers in the Multi-Utilities industry. AQNB scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. AQNB has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year AQNB was profitable.
AQNB had a positive operating cash flow in the past year.
In multiple years AQNB reported negative net income over the last 5 years.
Each year in the past 5 years AQNB had a positive operating cash flow.
AQNB Yearly Net Income VS EBIT VS OCF VS FCFAQNB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

AQNB's Return On Assets of -0.27% is on the low side compared to the rest of the industry. AQNB is outperformed by 96.15% of its industry peers.
The Return On Equity of AQNB (-0.80%) is worse than 96.15% of its industry peers.
The Return On Invested Capital of AQNB (3.16%) is worse than 88.46% of its industry peers.
The Average Return On Invested Capital over the past 3 years for AQNB is in line with the industry average of 3.96%.
The 3 year average ROIC (2.36%) for AQNB is below the current ROIC(3.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROIC 3.16%
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
AQNB Yearly ROA, ROE, ROICAQNB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

Looking at the Operating Margin, with a value of 21.55%, AQNB is in line with its industry, outperforming 53.85% of the companies in the same industry.
AQNB's Operating Margin has declined in the last couple of years.
AQNB has a better Gross Margin (73.94%) than 73.08% of its industry peers.
In the last couple of years the Gross Margin of AQNB has remained more or less at the same level.
Industry RankSector Rank
OM 21.55%
PM (TTM) N/A
GM 73.94%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
AQNB Yearly Profit, Operating, Gross MarginsAQNB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

4

2. Health

2.1 Basic Checks

AQNB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, AQNB has more shares outstanding
AQNB has more shares outstanding than it did 5 years ago.
AQNB has a better debt/assets ratio than last year.
AQNB Yearly Shares OutstandingAQNB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
AQNB Yearly Total Debt VS Total AssetsAQNB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

Based on the Altman-Z score of 1.31, we must say that AQNB is in the distress zone and has some risk of bankruptcy.
AQNB has a better Altman-Z score (1.31) than 96.15% of its industry peers.
A Debt/Equity ratio of 1.33 is on the high side and indicates that AQNB has dependencies on debt financing.
AQNB has a better Debt to Equity ratio (1.33) than 61.54% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Altman-Z 1.31
ROIC/WACC0.46
WACC6.86%
AQNB Yearly LT Debt VS Equity VS FCFAQNB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B

2.3 Liquidity

A Current Ratio of 1.23 indicates that AQNB should not have too much problems paying its short term obligations.
AQNB's Current ratio of 1.23 is amongst the best of the industry. AQNB outperforms 88.46% of its industry peers.
AQNB has a Quick Ratio of 1.03. This is a normal value and indicates that AQNB is financially healthy and should not expect problems in meeting its short term obligations.
AQNB has a Quick ratio of 1.03. This is amongst the best in the industry. AQNB outperforms 88.46% of its industry peers.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.03
AQNB Yearly Current Assets VS Current LiabilitesAQNB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

3

3. Growth

3.1 Past

The earnings per share for AQNB have decreased strongly by -29.79% in the last year.
AQNB shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.38% yearly.
The Revenue for AQNB has decreased by -23.92% in the past year. This is quite bad
AQNB shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.38% yearly.
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%

3.2 Future

Based on estimates for the next years, AQNB will show a small growth in Earnings Per Share. The EPS will grow by 4.09% on average per year.
Based on estimates for the next years, AQNB will show a small growth in Revenue. The Revenue will grow by 2.30% on average per year.
EPS Next Y-15.04%
EPS Next 2Y-0.53%
EPS Next 3Y5.89%
EPS Next 5Y4.09%
Revenue Next Year-10.84%
Revenue Next 2Y-3.85%
Revenue Next 3Y-1.19%
Revenue Next 5Y2.3%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
AQNB Yearly Revenue VS EstimatesAQNB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 500M 1B 1.5B 2B 2.5B
AQNB Yearly EPS VS EstimatesAQNB Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0.2 0.4 0.6

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 77.97, which means the current valuation is very expensive for AQNB.
Based on the Price/Earnings ratio, AQNB is valued more expensive than 96.15% of the companies in the same industry.
When comparing the Price/Earnings ratio of AQNB to the average of the S&P500 Index (26.15), we can say AQNB is valued expensively.
With a Price/Forward Earnings ratio of 70.28, AQNB can be considered very expensive at the moment.
Based on the Price/Forward Earnings ratio, AQNB is valued more expensive than 96.15% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of AQNB to the average of the S&P500 Index (36.22), we can say AQNB is valued expensively.
Industry RankSector Rank
PE 77.97
Fwd PE 70.28
AQNB Price Earnings VS Forward Price EarningsAQNB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of AQNB indicates a rather expensive valuation: AQNB more expensive than 96.15% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 28.68
AQNB Per share dataAQNB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-0.53%
EPS Next 3Y5.89%

6

5. Dividend

5.1 Amount

AQNB has a Yearly Dividend Yield of 4.24%, which is a nice return.
Compared to an average industry Dividend Yield of 3.37, AQNB pays a better dividend. On top of this AQNB pays more dividend than 88.46% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.32, AQNB pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.24%

5.2 History

The dividend of AQNB has a limited annual growth rate of 0.06%.
AQNB has been paying a dividend for over 5 years, so it has already some track record.
AQNB has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)0.06%
Div Incr Years1
Div Non Decr Years4
AQNB Yearly Dividends per shareAQNB Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

The earnings of AQNB are negative and hence is the payout ratio. AQNB will probably not be able to sustain this dividend level.
The dividend of AQNB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-569.86%
EPS Next 2Y-0.53%
EPS Next 3Y5.89%
AQNB Yearly Income VS Free CF VS DividendAQNB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079

NYSE:AQNB (12/2/2025, 8:27:07 PM)

After market: 25.7 -0.03 (-0.12%)

25.73

-0.01 (-0.04%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07 2025-11-07/bmo
Earnings (Next)03-05 2026-03-05/amc
Inst Owners71.48%
Inst Owner ChangeN/A
Ins Owners0.05%
Ins Owner ChangeN/A
Market Cap19.76B
Revenue(TTM)2.39B
Net Income(TTM)-37.22M
Analysts68.33
Price Target20.87 (-18.89%)
Short Float %0%
Short Ratio0.32
Dividend
Industry RankSector Rank
Dividend Yield 4.24%
Yearly Dividend0.41
Dividend Growth(5Y)0.06%
DP-569.86%
Div Incr Years1
Div Non Decr Years4
Ex-Date09-15 2025-09-15 (0.5412)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)17.46%
Min EPS beat(2)-0.69%
Max EPS beat(2)35.61%
EPS beat(4)2
Avg EPS beat(4)12.84%
Min EPS beat(4)-25.74%
Max EPS beat(4)42.17%
EPS beat(8)4
Avg EPS beat(8)5.61%
EPS beat(12)5
Avg EPS beat(12)1.98%
EPS beat(16)6
Avg EPS beat(16)-0.66%
Revenue beat(2)1
Avg Revenue beat(2)-0.52%
Min Revenue beat(2)-1.85%
Max Revenue beat(2)0.82%
Revenue beat(4)2
Avg Revenue beat(4)-0.08%
Min Revenue beat(4)-4.61%
Max Revenue beat(4)5.31%
Revenue beat(8)3
Avg Revenue beat(8)-1.75%
Revenue beat(12)6
Avg Revenue beat(12)-0.49%
Revenue beat(16)9
Avg Revenue beat(16)0.59%
PT rev (1m)-7.43%
PT rev (3m)-3.69%
EPS NQ rev (1m)-18.84%
EPS NQ rev (3m)-20.01%
EPS NY rev (1m)-0.06%
EPS NY rev (3m)0.4%
Revenue NQ rev (1m)-3.53%
Revenue NQ rev (3m)-3.47%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)0.72%
Valuation
Industry RankSector Rank
PE 77.97
Fwd PE 70.28
P/S 8.28
P/FCF N/A
P/OCF 42.44
P/B 4.26
P/tB 6.06
EV/EBITDA 28.68
EPS(TTM)0.33
EY1.28%
EPS(NY)0.37
Fwd EY1.42%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)0.61
OCFY2.36%
SpS3.11
BVpS6.05
TBVpS4.24
PEG (NY)N/A
PEG (5Y)N/A
Graham Number6.7
Profitability
Industry RankSector Rank
ROA -0.27%
ROE -0.8%
ROCE 4%
ROIC 3.16%
ROICexc 3.18%
ROICexgc 3.56%
OM 21.55%
PM (TTM) N/A
GM 73.94%
FCFM N/A
ROA(3y)-3.11%
ROA(5y)-0.39%
ROE(3y)-11.12%
ROE(5y)-2.83%
ROIC(3y)2.36%
ROIC(5y)2.31%
ROICexc(3y)2.37%
ROICexc(5y)2.33%
ROICexgc(3y)2.6%
ROICexgc(5y)2.56%
ROCE(3y)2.99%
ROCE(5y)2.93%
ROICexgc growth 3Y4.3%
ROICexgc growth 5Y-5.03%
ROICexc growth 3Y4.14%
ROICexc growth 5Y-4.63%
OM growth 3Y3.93%
OM growth 5Y-3.09%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.98%
GM growth 5Y0.16%
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 1.33
Debt/FCF N/A
Debt/EBITDA 6.76
Cap/Depr 208.02%
Cap/Sales 34.55%
Interest Coverage 1.49
Cash Conversion 51.11%
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.03
Altman-Z 1.31
F-Score4
WACC6.86%
ROIC/WACC0.46
Cap/Depr(3y)213.94%
Cap/Depr(5y)245.17%
Cap/Sales(3y)39.89%
Cap/Sales(5y)45.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.79%
EPS 3Y-19.53%
EPS 5Y-10.38%
EPS Q2Q%12.5%
EPS Next Y-15.04%
EPS Next 2Y-0.53%
EPS Next 3Y5.89%
EPS Next 5Y4.09%
Revenue 1Y (TTM)-23.92%
Revenue growth 3Y0.49%
Revenue growth 5Y7.38%
Sales Q2Q%1.66%
Revenue Next Year-10.84%
Revenue Next 2Y-3.85%
Revenue Next 3Y-1.19%
Revenue Next 5Y2.3%
EBIT growth 1Y-15.87%
EBIT growth 3Y4.45%
EBIT growth 5Y4.06%
EBIT Next Year40.67%
EBIT Next 3Y19.82%
EBIT Next 5YN/A
FCF growth 1Y-47.31%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-27.45%
OCF growth 3Y45.17%
OCF growth 5Y-4.65%

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 / AQNB FAQ

Can you provide the ChartMill fundamental rating for ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079?

ChartMill assigns a fundamental rating of 3 / 10 to AQNB.


What is the valuation status for AQNB stock?

ChartMill assigns a valuation rating of 0 / 10 to ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB). This can be considered as Overvalued.


How profitable is ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) stock?

ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) has a profitability rating of 3 / 10.


Can you provide the expected EPS growth for AQNB stock?

The Earnings per Share (EPS) of ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) is expected to decline by -15.04% in the next year.


How sustainable is the dividend of ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) stock?

The dividend rating of ALGONQUIN PWR & UTILITY - AQNCN 8.65912 07/01/2079 (AQNB) is 6 / 10 and the dividend payout ratio is -569.86%.